Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Mar 30;41(16):2963–2974. doi: 10.1200/JCO.22.02120

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by American Society of Clinical Oncology

Licensed under the Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/

PMC Copyright notice

FIG 3. — (A) CIR and (B) OS curves to visually compare (with a 90-day landmark) patients who did and did not receive allo-SCT in CR1. (C) CIR and (D) OS curves to visually compare (with a 90-day landmark) patients who did and did not receive allo-SCT in CR1 stratified by KMT2A fusion partner-based risk group. P values are not shown as these figures are only used for visual comparison. allo-SCT, allogeneic stem-cell transplantation; CIR, cumulative incidence of relapse; CR1, first complete remission; OS, overall survival.